Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett, page-54

There is one thing that Dr.T is consistent is- “ He has been buying shares in RAC, ever since being involved in it. “
Everybody needs to do their own DD, the same way Dr.T did, before he got involved.
Mason’s also spent 100s of hours on FTO aspects of RAC and shared his research.
That was before the biggest breakthrough of cardioprotection.
The way Dr.T keeps loading up RAC. It seems to me- Deals are the ideal way for him to exit the stock. It also aligns with the majority of shareholders.
Anyone who thinks RAC can’t get any deals done, or we won’t have more than 1 Pharma interested, just wait and see, what happens after some clinical readouts.
Dont let the share price dictate your view- it’s not doom and gloom , IMO. A little bit of patience will go a long way.